Zydol Drug Interactions

Benzodiazepines and Other Central Nervous System (CNS) Depressants: The concomitant use of Butorphanol Tartrate Injection with benzodiazepines or other CNS depressants - such as alcohol, sedatives, hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, or other opioids - can lead to additive effects. This significantly increases the risk of low blood pressure, respiratory depression, excessive sedation, coma, and even death.
These drugs should only be prescribed together when other treatment options are not effective or appropriate. Use the lowest effective dose for the shortest possible time, and monitor patients closely for signs of breathing problems and excessive drowsiness.
Serotonergic Drugs: Concomitant use of opioids, including butorphanol, with medications that affect the serotonergic system - such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 antagonists, serotonin-active agents (e.g., mirtazapine, trazodone, tramadol), certain muscle relaxants (e.g., cyclobenzaprine, metaxalone), and monoamine oxidase inhibitors (MAOIs, including linezolid and IV methylene blue) - may increase the risk of serotonin syndrome.
If concurrent use is necessary, closely monitor patients, especially during treatment initiation and dose adjustments. Discontinue Butorphanol Tartrate Injection immediately if serotonin syndrome is suspected.
Cytochrome P450 (CYP450) Interactions: It is currently unknown whether the effects of Butorphanol Tartrate Injection are altered by medications that influence liver enzymes responsible for drug metabolism (CYP450 inhibitors or inducers), such as erythromycin or theophylline. Clinicians should remain cautious and consider initiating treatment with a lower dose and increasing the dosing interval when such drugs are used concurrently.
Monoamine Oxidase Inhibitors (MAOIs): There is no available data regarding the concurrent use of butorphanol with MAOIs. Patients should be advised to avoid using these medications together.